ERBB2 and breast cancer: Nobiletin induces G0/G1 cell cycle arrest by inhibiting ERK1/2 signaling, leading to upregulation of p21 and downregulation of cyclin D1 expressions in MCF-7, HER2-positive SK-BR-3, and triple-negative MDA-MB-468 BC cell lines [107].